Global Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023

July 2018 | 132 pages | ID: GC84C08A8B1EN
GlobalInfoResearch

Abstracts

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

SCOPE OF THE REPORT:

This report studies the Oncolytic Virus Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Therapy market by product type and applications/end industries.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%.
Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry.
The global Oncolytic Virus Therapy market is valued at 2 million USD in 2017 and is expected to reach 10 million USD by the end of 2023, growing at a CAGR of 25.8% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncolytic Virus Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers

• Amgen
• Oncolytics Biotech
• Viralytics
• Transgene SA
• Oncolys BioPharma
• Targovax
• PsiOxus Therapeutics
• SillaJen Biotherapeutics
• Sorrento Therapeutics
• Lokon Pharma
• Genelux Corporation
• Vyriad
• TILT Biotherapeutics
• Cold Genesys

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers

• HSV-based Oncolytic Viruses
• Adenoviruses-based Oncolytic Viruses
• Vaccinia Virus-based Oncolytic Viruses
• Vesicular Stomatitis Virus-based Oncolytic Viruses
• Newcastle Disease Virus-based Oncolytic Viruses

Market Segment by Applications, can be divided into

• Melanoma
• Prostate Cancer
• Breast Cancer
• Ovarian Cancer
• Others

Contents

1 ONCOLYTIC VIRUS THERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Oncolytic Virus Therapy
1.2 Classification of Oncolytic Virus Therapy by Types
  1.2.1 Global Oncolytic Virus Therapy Revenue Comparison by Types (2017-2023)
  1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Types in 2017
  1.2.3 HSV-based Oncolytic Viruses
  1.2.4 Adenoviruses-based Oncolytic Viruses
  1.2.5 Vaccinia Virus-based Oncolytic Viruses
  1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
  1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
1.3 Global Oncolytic Virus Therapy Market by Application
  1.3.1 Global Oncolytic Virus Therapy Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Melanoma
  1.3.3 Prostate Cancer
  1.3.4 Breast Cancer
  1.3.5 Ovarian Cancer
  1.3.6 Others
1.4 Global Oncolytic Virus Therapy Market by Regions
  1.4.1 Global Oncolytic Virus Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Oncolytic Virus Therapy Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncolytic Virus Therapy Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncolytic Virus Therapy Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Oncolytic Virus Therapy Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncolytic Virus Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Oncolytic Virus Therapy (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Amgen
  2.1.1 Business Overview
  2.1.2 Oncolytic Virus Therapy Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oncolytics Biotech
  2.2.1 Business Overview
  2.2.2 Oncolytic Virus Therapy Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Viralytics
  2.3.1 Business Overview
  2.3.2 Oncolytic Virus Therapy Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Transgene SA
  2.4.1 Business Overview
  2.4.2 Oncolytic Virus Therapy Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oncolys BioPharma
  2.5.1 Business Overview
  2.5.2 Oncolytic Virus Therapy Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Targovax
  2.6.1 Business Overview
  2.6.2 Oncolytic Virus Therapy Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 PsiOxus Therapeutics
  2.7.1 Business Overview
  2.7.2 Oncolytic Virus Therapy Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 SillaJen Biotherapeutics
  2.8.1 Business Overview
  2.8.2 Oncolytic Virus Therapy Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sorrento Therapeutics
  2.9.1 Business Overview
  2.9.2 Oncolytic Virus Therapy Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lokon Pharma
  2.10.1 Business Overview
  2.10.2 Oncolytic Virus Therapy Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genelux Corporation
  2.11.1 Business Overview
  2.11.2 Oncolytic Virus Therapy Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vyriad
  2.12.1 Business Overview
  2.12.2 Oncolytic Virus Therapy Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.13 TILT Biotherapeutics
  2.13.1 Business Overview
  2.13.2 Oncolytic Virus Therapy Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.14 Cold Genesys
  2.14.1 Business Overview
  2.14.2 Oncolytic Virus Therapy Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET COMPETITION, BY PLAYERS

3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Oncolytic Virus Therapy Players Market Share
  3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share
3.3 Market Competition Trend

4 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET SIZE BY REGIONS

4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Regions
4.2 North America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ONCOLYTIC VIRUS THERAPY REVENUE BY COUNTRIES

5.1 North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
5.2 USA Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

6 EUROPE ONCOLYTIC VIRUS THERAPY REVENUE BY COUNTRIES

6.1 Europe Oncolytic Virus Therapy Revenue by Countries (2013-2018)
6.2 Germany Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
6.4 France Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC ONCOLYTIC VIRUS THERAPY REVENUE BY COUNTRIES

7.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Countries (2013-2018)
7.2 China Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
7.5 India Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA ONCOLYTIC VIRUS THERAPY REVENUE BY COUNTRIES

8.1 South America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
8.2 Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE ONCOLYTIC VIRUS THERAPY BY COUNTRIES

9.1 Middle East and Africa Oncolytic Virus Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)

10 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET SEGMENT BY TYPE

10.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Oncolytic Virus Therapy Market Forecast by Type (2018-2023)
10.3 HSV-based Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.4 Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.5 Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.6 Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2023)
10.7 Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2023)

11 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET SEGMENT BY APPLICATION

11.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2013-2018)
11.2 Oncolytic Virus Therapy Market Forecast by Application (2018-2023)
11.3 Melanoma Revenue Growth (2013-2018)
11.4 Prostate Cancer Revenue Growth (2013-2018)
11.5 Breast Cancer Revenue Growth (2013-2018)
11.6 Ovarian Cancer Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)

12 GLOBAL ONCOLYTIC VIRUS THERAPY MARKET SIZE FORECAST (2018-2023)

12.1 Global Oncolytic Virus Therapy Market Size Forecast (2018-2023)
12.2 Global Oncolytic Virus Therapy Market Forecast by Regions (2018-2023)
12.3 North America Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
12.6 South America Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oncolytic Virus Therapy Picture
Table Product Specifications of Oncolytic Virus Therapy
Table Global Oncolytic Virus Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Oncolytic Virus Therapy Revenue Market Share by Types in 2017
Figure HSV-based Oncolytic Viruses Picture
Figure Adenoviruses-based Oncolytic Viruses Picture
Figure Vaccinia Virus-based Oncolytic Viruses Picture
Figure Vesicular Stomatitis Virus-based Oncolytic Viruses Picture
Figure Newcastle Disease Virus-based Oncolytic Viruses Picture
Table Global Oncolytic Virus Therapy Revenue (Million USD) by Application (2013-2023)
Figure Oncolytic Virus Therapy Revenue Market Share by Applications in 2017
Figure Melanoma Picture
Figure Prostate Cancer Picture
Figure Breast Cancer Picture
Figure Ovarian Cancer Picture
Figure Others Picture
Table Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Oncolytic Virus Therapy Type and Applications
Table Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolytics Biotech Basic Information, Manufacturing Base and Competitors
Table Oncolytics Biotech Oncolytic Virus Therapy Type and Applications
Table Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Viralytics Basic Information, Manufacturing Base and Competitors
Table Viralytics Oncolytic Virus Therapy Type and Applications
Table Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Transgene SA Basic Information, Manufacturing Base and Competitors
Table Transgene SA Oncolytic Virus Therapy Type and Applications
Table Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Oncolys BioPharma Basic Information, Manufacturing Base and Competitors
Table Oncolys BioPharma Oncolytic Virus Therapy Type and Applications
Table Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Targovax Basic Information, Manufacturing Base and Competitors
Table Targovax Oncolytic Virus Therapy Type and Applications
Table Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table PsiOxus Therapeutics Basic Information, Manufacturing Base and Competitors
Table PsiOxus Therapeutics Oncolytic Virus Therapy Type and Applications
Table PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table SillaJen Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Oncolytic Virus Therapy Type and Applications
Table Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Lokon Pharma Basic Information, Manufacturing Base and Competitors
Table Lokon Pharma Oncolytic Virus Therapy Type and Applications
Table Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Genelux Corporation Basic Information, Manufacturing Base and Competitors
Table Genelux Corporation Oncolytic Virus Therapy Type and Applications
Table Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Vyriad Basic Information, Manufacturing Base and Competitors
Table Vyriad Oncolytic Virus Therapy Type and Applications
Table Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table TILT Biotherapeutics Oncolytic Virus Therapy Type and Applications
Table TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Cold Genesys Basic Information, Manufacturing Base and Competitors
Table Cold Genesys Oncolytic Virus Therapy Type and Applications
Table Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Oncolytic Virus Therapy Revenue (Million USD) by Players (2013-2018)
Table Global Oncolytic Virus Therapy Revenue Share by Players (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Share by Players in 2016
Figure Global Oncolytic Virus Therapy Revenue Share by Players in 2017
Figure Global Top 5 Players Oncolytic Virus Therapy Revenue Market Share in 2017
Figure Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2017
Figure Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Oncolytic Virus Therapy Revenue (Million USD) by Regions (2013-2018)
Table Global Oncolytic Virus Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Regions (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Market Share by Regions in 2017
Figure North America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table North America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Table North America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure North America Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure USA Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Canada Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Europe Oncolytic Virus Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure Europe Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Germany Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure UK Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure France Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Russia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Italy Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Oncolytic Virus Therapy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure China Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Japan Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Korea Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure India Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table South America Oncolytic Virus Therapy Revenue by Countries (2013-2018)
Table South America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure South America Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Colombia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure UAE Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Egypt Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure Nigeria Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Figure South Africa Oncolytic Virus Therapy Revenue and Growth Rate (2013-2018)
Table Global Oncolytic Virus Therapy Revenue (Million USD) by Type (2013-2018)
Table Global Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Share by Type (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Share by Type in 2017
Table Global Oncolytic Virus Therapy Revenue Forecast by Type (2018-2023)
Figure Global Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
Figure Global HSV-based Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Adenoviruses-based Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Vaccinia Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2018)
Figure Global Newcastle Disease Virus-based Oncolytic Viruses Revenue Growth Rate (2013-2018)
Table Global Oncolytic Virus Therapy Revenue by Application (2013-2018)
Table Global Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Share by Application (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue Share by Application in 2017
Table Global Oncolytic Virus Therapy Revenue Forecast by Application (2018-2023)
Figure Global Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)
Figure Global Melanoma Revenue Growth Rate (2013-2018)
Figure Global Prostate Cancer Revenue Growth Rate (2013-2018)
Figure Global Breast Cancer Revenue Growth Rate (2013-2018)
Figure Global Ovarian Cancer Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Oncolytic Virus Therapy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Oncolytic Virus Therapy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Oncolytic Virus Therapy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
Figure Europe Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
Figure South America Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Oncolytic Virus Therapy Revenue Market Forecast (2018-2023)